Interdisciplinary cardiovascular and thoracic surgery · 2025
Development, Validation, and Testing of a Simple Risk Score System Incorporating Routine Clinical and Laboratory Variables to Predict Moderate-to-Severe Acute Kidney Injury After Cardiac Surgery.
СтатьяВалидационное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Su Xiaoting, Zeng Juntong, Lin Shen, Li Zhongchen, Huang Xiaohong, Zhao Yan, Liu Sheng, Zheng Zhe
Аннотация
OBJECTIVES: Early prediction is crucial for cardiac surgery-associated acute kidney injury (CSA-AKI). We aimed to develop and validate a simple, clinical- and laboratory-based risk score system for better CSA-AKI prediction.
METHODS: We developed a new pre-operative risk score system for moderate-to-severe CSA-AKI in a 10-year cohort of patients undergoing coronary artery bypass grafting at one tertiary centre. Most predictive laboratory and clinical variables were identified and constituted a simple and a full model. External testing was performed in patients at another centre. The risk score system was compared with 2 established clinical models.
RESULTS: The overall cohort comprised 27 534, 6403, and 1733 patients with moderate-to-severe CSA-AKI rates of 3.3%, 2.8%, and 8.4% for training, validation, and external testing, respectively. A simple 6-variable AB2C-S2 score (Age, Biomarkers of N-terminal pro-B-type natriuretic peptide and haemoglobin, Clinical history of preoperative critical state, Surgical factors of isolated surgery and on-pump surgery) and a full 9-variable AB2C2-S4 score (AB2C-S2 score plus hypertension, urgent surgery, and previous surgery) were developed. The simple model achieved similar performance as the full model in validation (area under the receiver-operating characteristic curve [AUC] 0.78 vs 0.79, P = .37) and external testing (AUC 0.74 vs 0.75, P = .17), and both significantly outperformed than 2 established clinical models: Cleveland Clinic model (validation: AUC 0.71, external testing: AUC 0.65, all P < .001) and Ng model (validation: AUC 0.64, external testing: AUC 0.65, all P < .001).
CONCLUSIONS: A simple preoperative risk score system for moderate-to-severe CSA-AKI was developed and outperformed established complex clinical models.
METHODS: We developed a new pre-operative risk score system for moderate-to-severe CSA-AKI in a 10-year cohort of patients undergoing coronary artery bypass grafting at one tertiary centre. Most predictive laboratory and clinical variables were identified and constituted a simple and a full model. External testing was performed in patients at another centre. The risk score system was compared with 2 established clinical models.
RESULTS: The overall cohort comprised 27 534, 6403, and 1733 patients with moderate-to-severe CSA-AKI rates of 3.3%, 2.8%, and 8.4% for training, validation, and external testing, respectively. A simple 6-variable AB2C-S2 score (Age, Biomarkers of N-terminal pro-B-type natriuretic peptide and haemoglobin, Clinical history of preoperative critical state, Surgical factors of isolated surgery and on-pump surgery) and a full 9-variable AB2C2-S4 score (AB2C-S2 score plus hypertension, urgent surgery, and previous surgery) were developed. The simple model achieved similar performance as the full model in validation (area under the receiver-operating characteristic curve [AUC] 0.78 vs 0.79, P = .37) and external testing (AUC 0.74 vs 0.75, P = .17), and both significantly outperformed than 2 established clinical models: Cleveland Clinic model (validation: AUC 0.71, external testing: AUC 0.65, all P < .001) and Ng model (validation: AUC 0.64, external testing: AUC 0.65, all P < .001).
CONCLUSIONS: A simple preoperative risk score system for moderate-to-severe CSA-AKI was developed and outperformed established complex clinical models.